Tech Company Financing Transactions
Emmaus Life Sciences Funding Round
Private investors participated in a $20 million funding round for Emmaus Life Sciences. The funding round was recorded on 10/17/2016.
Transaction Overview
Company Name
Announced On
10/17/2016
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
21250 Hawthorne Blvd. 800
Torrance, CA 90503
USA
Torrance, CA 90503
USA
Phone
Website
Email Address
Overview
Emmaus Life Sciences, Inc. is conducting a clinical trial for L-glutamine for sickle cell disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yutaka Niihara
Chief Operating Officer
Willis Lee
VP - Administration
Lan Tran
VP - Finance
Yasushi Nagasaki
VP - R & D
Charles Stark
Browse more venture capital transactions:
Prev: 10/17/2016: Sonavation venture capital transaction
Next: 10/18/2016: CloudLex venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs